thiazoles has been researched along with soblidotin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukumoto, H; Kobayashi, M; Koh, Y; Nakamura, T; Natsume, T; Nishio, K; Ohe, Y; Saijo, N; Takahashi, F | 1 |
Kobayashi, M; Natsume, T; Watanabe, J | 1 |
Banerjee, S; Mohammad, M; Mohammad, RM; Sarkar, FH; Wang, Z | 1 |
1 review(s) available for thiazoles and soblidotin
Article | Year |
---|---|
Efficacy of selected natural products as therapeutic agents against cancer.
Topics: Animals; Antineoplastic Agents; Biological Products; Bryostatins; Depsipeptides; Humans; Models, Biological; Molecular Structure; Oligopeptides; Stilbenes; Thiazoles | 2008 |
2 other study(ies) available for thiazoles and soblidotin
Article | Year |
---|---|
Enhanced antitumor activities of TZT-1027 against TNF-alpha or IL-6 secreting Lewis lung carcinoma in vivo.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; DNA, Complementary; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Interleukin-6; LLC-PK1 Cells; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Oligopeptides; RNA, Neoplasm; Tetrazolium Salts; Thiazoles; Transfection; Tumor Necrosis Factor-alpha | 2002 |
Comparison of the antivascular and cytotoxic activities of TZT-1027 (Soblidotin) with those of other anticancer agents.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Colonic Neoplasms; Dextrans; Diffusion; Endothelial Cells; Endothelium, Vascular; Female; Fluorescein-5-isothiocyanate; Humans; Indicators and Reagents; Mice; Mice, Inbred BALB C; Oligopeptides; Tetrazolium Salts; Thiazoles; Umbilical Veins | 2007 |